gabapentin
Generic: gabapentin
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
mylan pharmaceuticals inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
gabapentin 250 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
59762-5050
Product ID
59762-5050_f5c6e992-4771-4c56-ac1f-00ccfb88bef5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA021129
Listing Expiration
2026-12-31
Marketing Start
2022-07-01
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
597625050
Hyphenated Format
59762-5050
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
NDA021129 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/5mL
Packaging
- 1 BOTTLE, PLASTIC in 1 CARTON (59762-5050-7) / 470 mL in 1 BOTTLE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f5c6e992-4771-4c56-ac1f-00ccfb88bef5", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "spl_set_id": ["cff7de45-148b-4e96-88fd-6052bf75b5f7"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (59762-5050-7) / 470 mL in 1 BOTTLE, PLASTIC", "package_ndc": "59762-5050-7", "marketing_start_date": "20220701"}], "brand_name": "GABAPENTIN", "product_id": "59762-5050_f5c6e992-4771-4c56-ac1f-00ccfb88bef5", "dosage_form": "SUSPENSION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "59762-5050", "generic_name": "gabapentin", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "250 mg/5mL"}], "application_number": "NDA021129", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20220701", "listing_expiration_date": "20261231"}